Javascript must be enabled to continue!
Inhibitory Effects of Bifidobacterium longum on Experimental Ulcerative Colitis Induced in Mice by Synthetic Dextran Sulfate Sodium
View through CrossRef
Background/Aims: The relationship between alterations in intestinal microflora and ulcerative colitis is still not clear. Whether improvement in bacterial populations might be a new strategy for prevention or treatment needs to be tested. Methods: Ulcerative colitis was induced in mice by oral administration of synthetic dextran sulfate sodium (molecular weight 54,000). Inhibitory effects of concomitant treatment with Bifidobacterium longum were assessed in terms of total colon length and severity of histological changes. In addition, changes of microflora and short-chain fatty acids were tested in fecal samples and compared before and after treatment. Results: Administration of B. longum significantly inhibited both shortening of total colon length and the severity of ulcerative colitis compared to controls. It was confirmed that the administered B. longum resided in the gut and blocked the decrease of lactobacilli in fecal samples in mice with dextran sulfate sodium-induced colitis. Conclusions: Oral administration of B. longum exerts marked inhibitory effects on ulcerative colitis in mice.
Title: Inhibitory Effects of Bifidobacterium longum on Experimental Ulcerative Colitis Induced in Mice by Synthetic Dextran Sulfate Sodium
Description:
Background/Aims: The relationship between alterations in intestinal microflora and ulcerative colitis is still not clear.
Whether improvement in bacterial populations might be a new strategy for prevention or treatment needs to be tested.
Methods: Ulcerative colitis was induced in mice by oral administration of synthetic dextran sulfate sodium (molecular weight 54,000).
Inhibitory effects of concomitant treatment with Bifidobacterium longum were assessed in terms of total colon length and severity of histological changes.
In addition, changes of microflora and short-chain fatty acids were tested in fecal samples and compared before and after treatment.
Results: Administration of B.
longum significantly inhibited both shortening of total colon length and the severity of ulcerative colitis compared to controls.
It was confirmed that the administered B.
longum resided in the gut and blocked the decrease of lactobacilli in fecal samples in mice with dextran sulfate sodium-induced colitis.
Conclusions: Oral administration of B.
longum exerts marked inhibitory effects on ulcerative colitis in mice.
Related Results
P704 Bifidobacterium longum species protect murine colitis through different activation repertoires of immune cells
P704 Bifidobacterium longum species protect murine colitis through different activation repertoires of immune cells
Abstract
Background
Inflammatory bowel disease (IBD) is a chronic disease that causes an inappropriate immune response due to ge...
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Abstract
Introduction
Among the most frequently used anticoagulants in hematological testing are tetra-acetic acid (EDTA), sodium citrate, and sodium heparin. However, there is a n...
Evaluasi Deteksi Berbasis PCR untuk Bakteri Bifidobacterium longum dalam Sampel Feses Bayi dari Kota Manado
Evaluasi Deteksi Berbasis PCR untuk Bakteri Bifidobacterium longum dalam Sampel Feses Bayi dari Kota Manado
Bifidobakteria merupakan mikroflora yang umum hidup dalam usus manusia sejak bayi. Peran Bifidobacterium longum yang positif sebagai salah satu bakteri yang menunjang kesehatan ina...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated Anemia
Endotoxemia As Possible Cause of Inflammatory Bowel Diseases-Associated Anemia
Inflammatory bowel diseases (IBD), which include Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory conditions of the gastrointestinal tract and highly preva...
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
Pharmacological correction of ulcerative colitis with dalargin
Pharmacological correction of ulcerative colitis with dalargin
Introduction: Ulcerative colitis is a chronic colonic disease with frequent relapses, affecting mainly people of active age. The effectiveness of existing treatment methods remains...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...

